Clinical trials recruiting in Cuneo, Italy

Phase breakdown

Conditions recruiting in Cuneo, Italy

Recruiting trials in Cuneo, Italy

• A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
  NCT06077760 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
  NCT07082738 · Phase: Phase 2 · Ages: 40 Years and older · Sex: All (male and female)
• Atezolizumab and Rechallenge Chemotherapy in Relapsed Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC).
  NCT06663098 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
  NCT06531824 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• PREgnancy and FERtility Registry
  NCT02895165 · Phase: Not specified · Ages: 18 Years to 45 Years · Sex: Female
• PSMA PET for Treatment Response evaLuation of systemIC Therapies in prostAte caNcer (PELICAN)
  NCT07089550 · Phase: Not specified · Ages: 18 Years and older · Sex: Male
• Pilot Study: Parkinson's Conventional Physiotherapy vs Home-based Telerehabilitation
  NCT06052280 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Cuneo, Italy?

7 recruiting trials have at least one study site in Cuneo, Italy.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.